265 related articles for article (PubMed ID: 21823521)
1. The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia.
Cetinkaya S; Kara C
J Pediatr Endocrinol Metab; 2011; 24(5-6):265-9. PubMed ID: 21823521
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-term glucocorticoid therapy on bone mineral density of the patients with congenital adrenal hyperplasia.
Ünal S; Alikaşifoğlu A; Özön A; Gönç N; Kandemir N
Turk J Pediatr; 2020; 62(3):359-366. PubMed ID: 32558409
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Bone Mineral Parameters with Anthropometric Measurements and the Effect of Glucocorticoids on Bone Mineral Parameters in Congenital Adrenal Hyperplasia.
Ganesh R; Suresh N; Janakiraman L; Ravikumar K
Indian J Pediatr; 2016 Feb; 83(2):126-30. PubMed ID: 26223873
[TBL] [Abstract][Full Text] [Related]
4. Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue.
Halper A; Sanchez B; Hodges JS; Dengel DR; Petryk A; Sarafoglou K
Clin Endocrinol (Oxf); 2019 Jul; 91(1):124-130. PubMed ID: 31070802
[TBL] [Abstract][Full Text] [Related]
5. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia.
Girgis R; Winter JS
J Clin Endocrinol Metab; 1997 Dec; 82(12):3926-9. PubMed ID: 9398689
[TBL] [Abstract][Full Text] [Related]
6. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.
Guo CY; Weetman AP; Eastell R
Clin Endocrinol (Oxf); 1996 Nov; 45(5):535-41. PubMed ID: 8977749
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density and body composition in prepubertal and adolescent patients with the classical form of 21-hydroxylase deficiency.
Sahakitrungruang T; Wacharasindhu S; Supornsilchai V; Srivuthana S; Kingpetch K
J Med Assoc Thai; 2008 May; 91(5):705-10. PubMed ID: 18672636
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
Koetz KR; Ventz M; Diederich S; Quinkler M
J Clin Endocrinol Metab; 2012 Jan; 97(1):85-92. PubMed ID: 21994966
[TBL] [Abstract][Full Text] [Related]
9. [Estimation of influence of congenital-adrenal hyperplasia treatment on bone mineralisation evaluated with densitometry].
Romanowska H; Krzywińska-Zdeb E; Giżewska M; Kotkowiak L; Safranow K; Horodnicka-Józwa A; Petriczko E; Krupa B; Walczak M
Pediatr Endocrinol Diabetes Metab; 2012; 18(1):21-6. PubMed ID: 22525687
[TBL] [Abstract][Full Text] [Related]
10. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density.
de Almeida Freire PO; de Lemos-Marini SH; Maciel-Guerra AT; Morcillo AM; Matias Baptista MT; de Mello MP; Guerra G
J Bone Miner Metab; 2003; 21(6):396-401. PubMed ID: 14586796
[TBL] [Abstract][Full Text] [Related]
11. Real-world impact of glucocorticoid replacement therapy on bone mineral density: retrospective experience of a large single-center CAH cohort spanning 24 years.
Iervolino LL; Ferraz-de-Souza B; Martin RM; Costa FC; Miranda MC; Mendonça BB; Bachega TS
Osteoporos Int; 2020 May; 31(5):905-912. PubMed ID: 31897546
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia.
Falhammar H; Filipsson Nyström H; Wedell A; Brismar K; Thorén M
Eur J Endocrinol; 2013 Mar; 168(3):331-41. PubMed ID: 23211577
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density in girls with classical congenital adrenal hyperplasia due to CYP21 deficiency.
Elnecave RH; Kopacek C; Rigatto M; Keller Brenner J; Sisson de Castro JA
J Pediatr Endocrinol Metab; 2008 Dec; 21(12):1155-62. PubMed ID: 19189689
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density and body composition in children with congenital adrenal hyperplasia.
Halper A; Sanchez B; Hodges JS; Kelly AS; Dengel D; Nathan BM; Petryk A; Sarafoglou K
Clin Endocrinol (Oxf); 2018 Jun; 88(6):813-819. PubMed ID: 29460378
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density and body composition in congenital adrenal hyperplasia.
Cameron FJ; Kaymakci B; Byrt EA; Ebeling PR; Warne GL; Wark JD
J Clin Endocrinol Metab; 1995 Jul; 80(7):2238-43. PubMed ID: 7608286
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia.
Gussinyé M; Carrascosa A; Potau N; Enrubia M; Vicens-Calvet E; Ibáñez L; Yeste D
Pediatrics; 1997 Oct; 100(4):671-4. PubMed ID: 9310523
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral status, bone turnover markers and vitamin D status in children with congenital adrenal hyperplasia.
Okten A; Cakir M; Makuloglu M
Minerva Endocrinol; 2012 Sep; 37(3):275-82. PubMed ID: 22766894
[TBL] [Abstract][Full Text] [Related]
18. Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome.
Minetto M; Reimondo G; Osella G; Ventura M; Angeli A; Terzolo M
Osteoporos Int; 2004 Nov; 15(11):855-61. PubMed ID: 15034643
[TBL] [Abstract][Full Text] [Related]
19. Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency.
Schulz J; Frey KR; Cooper MS; Zopf K; Ventz M; Diederich S; Quinkler M
Eur J Endocrinol; 2016 Apr; 174(4):531-8. PubMed ID: 26811406
[TBL] [Abstract][Full Text] [Related]
20. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM; Simm D; Beier C; Dörr HG
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
